Skip to main content
. 2023 Oct 24;2023(10):CD013584. doi: 10.1002/14651858.CD013584.pub2

Gulielmos 2000 (A).

Study characteristics
Methods Prospective, randomised trial
Run‐in period: not specified
Received: 14 December 1999
Received in revised form: 14 July 2000
Accepted: 15 August 2000
Number of study centres and locations: single centre, Cardiovascular Institute, University Hospital Dresden, Fetscherstrasse 76, 01307 Dresden, Germany
Participants Thirteen participants included in part A of this study
Four surgical techniques were compared: group 1, median sternotomy with CPB in 10 patients; group 2, median sternotomy and off‐pump in 10 patients; group 3, mini‐thoracotomy with CPB in 10 patients; group 4, mini‐thoracotomy and off‐pump in 10 patients.
Mean age: 63.73 years
Sex (female/male ratio): 30%
No high‐risk patients
Inclusion criteria: single LIMA bypass to the LAD, because of CAD or patients suffering from coronary artery double‐vessel or multivessel disease, with only the LAD being amenable for surgery
Exclusion criteria: impaired LVEF (< 30%), with impaired lung and renal function, unstable angina, major calcification of the ascending aorta, and obesity (BMI ≥30)
Interventions Intervention group: median sternotomy and off‐pump. At surgery over a median sternotomy using stay sutures between the left half of the pericardium and the soft tissue, the heart was rotated to the right, resulting in medialisation of the LAD, thus providing better access to this coronary vessel. Using the 'Octopus' (Octopus; Medtronic, Inc.), the coronary artery was occluded using a snare (4.0 Prolene; Ethicon, Norderstedt, Germany). After preconditioning (20 minutes temporary occlusion of the coronary vessel, reperfusion 20 minutes, and again occlusion for the anastomosis), the anastomosis was performed with the aid of an air blower to keep the operative sites free from blood.
Control group: median sternotomy with CPB
Outcomes IL‐1, IL‐6, and myocardial enzyme (troponin T and CK‐MB; clinical data (major complications, operative time, postoperative ventilation, CPB time [if used], cross‐clamping time, and coronary occlusion time)
Venous blood samples were drawn at the following times:
  1. at 5 minutes before induction of anaesthesia;

  2. on induction of CPB or occlusion of the LAD;

  3. at 15 minutes after induction of CPB or occlusion of the LAD;

  4. at 1 hour after induction of CPB or occlusion of the LAD;

  5. at 2 hours after induction of CPB or occlusion of the LAD;

  6. at 6 hours after induction of CPB or occlusion of the LAD;

  7. at 12 hours after induction of CPB or occlusion of the LAD;

  8. at 24 hours after induction of CPB or occlusion of the LAD; and

  9. at 48 hours after induction of CPB or occlusion of the LAD.

Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Between the four groups, there were no differences in terms of age, BMI, or incidence of previous infarction. No randomisation method description. One out of four techniques was prospectively chosen for each patient at random, but no other description about how the allocation was made is given.
Allocation concealment (selection bias) Unclear risk No clear description of allocation concealment
Blinding of participants and personnel (performance bias)
All outcomes Unclear risk Unspecified and unlikely because of the nature of the intervention
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Not specified
Incomplete outcome data (attrition bias)
All outcomes Low risk All procedures were completed as they were planned. No trial group changes, no withdrawals, and no losses to follow‐up were reported, but no intention‐to‐treat analysis. Data from all the participants were included in the final analysis.
Selective reporting (reporting bias) Unclear risk Clinical data were not properly reported as the other outcomes.
Other bias Low risk No funding was disclosed.